M-5

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameM-5
Drug Alias NameLys300His mutant pro-urokinaseM5
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionPlasminogen activators
TargetsPlasminogen
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHarvard Medical School
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHarvard Medical School
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A